The Vanderbilt Atrial Fibrillation Ablation Registry
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The Vanderbilt Atrial Fibrillation Ablation registry (VAFAR) is a prospective clinical and genetic biorepository that systematically enrolls patients undergoing atrial fibrillation (AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records with stored blood and DNA samples. The goals of VAFAR are to: 1) identify clinical, genetic, and serological predictors of response to AF ablation in order to improve patient selection, and 2) to provide a resource for translational research investigating the electrophysiologic mechanisms of AF pathogenesis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age \>18 years
• Able to give written, informed consent
• Scheduled for an ablation procedure to treat atrial fibrillation
Locations
United States
Tennessee
Vanderbilt University Medical Center
RECRUITING
Nashville
Contact Information
Primary
Moore B Shoemaker, MD, MSCI
615 322
Backup
Diane M Crawford, RN
Diane.m.crawford@vanderbilt.edu
615-936-6069
Time Frame
Start Date: 2011-10
Estimated Completion Date: 2028-10
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt University